Futility Study of Deferoxamine Mesylate in Intracerebral Hemorrhage Save

Date Added
April 21st, 2015
PRO Number
Pro00043124
Researcher
Charles Andrews
Keywords
Stroke
Summary

To assess whether deferoxamine mesylate (DFO) provides any benefit in individuals who suffer a spontaneous intracerebral hemorrhage (ICH). This study
will compare the outcomes of participants treated with deferoxamine mesylate (DFO) to those treated with a placebo.

Institution
MUSC
Recruitment Contact
Robert Burfeind
843-792-8606
burfeind@musc.edu

Change_preferences

-- OR --

Create_login